Literature DB >> 26045306

The Combination of Vascular Endothelial Growth Factor and Stromal Cell-Derived Factor Induces Superior Angiogenic Sprouting by Outgrowth Endothelial Cells.

Erin M Anderson1, David J Mooney.   

Abstract

Endothelial progenitor cells are being broadly explored for the treatment of ischemic cardiovascular diseases, but their response to molecules commonly used to promote the growth of new blood vessels has not been fully characterized. In this study, angiogenic sprout formation in a 3-dimensional, in vitro model by one type of endothelial progenitor, outgrowth endothelial cells (OECs), was characterized in response to exposure to stromal cell-derived factor (SDF) and vascular endothelial growth factor (VEGF) and then compared to mature endothelial cells. Exposure to SDF alone did not increase angiogenic sprouting in comparison to control media, while a combination of VEGF and SDF demonstrated greater potency than VEGF alone for all cell types. Together, VEGF and SDF reduced the sprout initiation time and maintained sprouting levels over time. In direct competition with mature endothelial cells, OECs preferentially localized to the tip cell position, suggesting an enhanced sprouting potential. Overall, these results reveal the impact of the combination of VEGF and SDF on endothelial cell sprouting, and support the enhanced potential of OECs, as opposed to mature endothelial cells, for treating ischemic diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26045306     DOI: 10.1159/000382129

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  8 in total

1.  Alginate hydrogels of varied molecular weight distribution enable sustained release of sphingosine-1-phosphate and promote angiogenesis.

Authors:  Priscilla A Williams; Kevin T Campbell; Eduardo A Silva
Journal:  J Biomed Mater Res A       Date:  2017-09-26       Impact factor: 4.396

2.  Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis.

Authors:  Priscilla A Williams; Kevin T Campbell; Hessam Gharaviram; Justin L Madrigal; Eduardo A Silva
Journal:  Ann Biomed Eng       Date:  2016-11-30       Impact factor: 3.934

Review 3.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

4.  Agent-based computational model of retinal angiogenesis simulates microvascular network morphology as a function of pericyte coverage.

Authors:  Joseph Walpole; Feilim Mac Gabhann; Shayn M Peirce; John C Chappell
Journal:  Microcirculation       Date:  2017-11       Impact factor: 2.679

5.  Rapid and chronological expression of angiogenetic genes is a major mechanism involved in cell sheet transplantation in a rat gastric ulcer model.

Authors:  Shun Yamaguchi; Miki Higashi; Kengo Kanetaka; Yasuhiro Maruya; Shinichiro Kobayashi; Keiichi Hashiguchi; Masaaki Hidaka; Kazuhiko Nakao; Susumu Eguchi
Journal:  Regen Ther       Date:  2022-09-11       Impact factor: 3.651

Review 6.  At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.

Authors:  Gary D Luker; Jinming Yang; Ann Richmond; Stefania Scala; Claudio Festuccia; Margret Schottelius; Hans-Jürgen Wester; Johann Zimmermann
Journal:  J Leukoc Biol       Date:  2020-10-26       Impact factor: 4.962

7.  Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications.

Authors:  Kevin T Campbell; Dustin J Hadley; David L Kukis; Eduardo A Silva
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

8.  The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen.

Authors:  Nan Geng; Jingwei Su; Zhikun Liu; Cuimin Ding; Shaonan Xie; Wenxia Hu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.